365 related articles for article (PubMed ID: 12529559)
1. The molecular perspective: VEGF and angiogenesis.
Goodsell DS
Stem Cells; 2003; 21(1):118-9. PubMed ID: 12529559
[No Abstract] [Full Text] [Related]
2. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
Zachary I
IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
[TBL] [Abstract][Full Text] [Related]
3. VEGF and the quest for tumour angiogenesis factors.
Ferrara N
Nat Rev Cancer; 2002 Oct; 2(10):795-803. PubMed ID: 12360282
[TBL] [Abstract][Full Text] [Related]
4. Regulators of angiogenesis as targets for anti-angiogenic tumor therapy.
Breier G; Heidenreich R; Gaumann A; Groot M; Licht A; Nicolaus A; Schmitz J; Reichmann E; Plate KH; Vajkoczy P
Ann Hematol; 2002; 81 Suppl 2():S71-2. PubMed ID: 12611084
[No Abstract] [Full Text] [Related]
5. The biology of VEGF and its receptors.
Ferrara N; Gerber HP; LeCouter J
Nat Med; 2003 Jun; 9(6):669-76. PubMed ID: 12778165
[TBL] [Abstract][Full Text] [Related]
6. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors.
Zielke A; Middeke M; Hoffmann S; Colombo-Benkmann M; Barth P; Hassan I; Wunderlich A; Hofbauer LC; Duh QY
Surgery; 2002 Dec; 132(6):1056-63; discussion 1063. PubMed ID: 12490855
[TBL] [Abstract][Full Text] [Related]
7. [Vascular endothelial growth factor receptor--structure and function].
Liu L; Hu BC; Zhang YJ
Sheng Li Ke Xue Jin Zhan; 2000 Jul; 31(3):269-72. PubMed ID: 12545721
[No Abstract] [Full Text] [Related]
8. Neuroblastoma, apoptosis, and growth factors.
Beierle EA; Dai W; Langham MR; Chen MK
Am Surg; 2003 Jan; 69(1):28-31. PubMed ID: 12575776
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor and its receptors in multiple myeloma.
Ria R; Roccaro AM; Merchionne F; Vacca A; Dammacco F; Ribatti D
Leukemia; 2003 Oct; 17(10):1961-6. PubMed ID: 14513045
[TBL] [Abstract][Full Text] [Related]
10. [Vascular endothelial growth factor--fundamental research and experimental study in plastic surgery].
Huang CY; Shen ZY
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Jan; 16(1):64-9. PubMed ID: 11826659
[TBL] [Abstract][Full Text] [Related]
11. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis in hematologic malignancies.
Mesters RM
Ann Hematol; 2002; 81 Suppl 2():S72-4. PubMed ID: 12611085
[No Abstract] [Full Text] [Related]
13. VEGFs, angiopoietins, Ephrins and their receptors: putative targets for tumor therapy?
Marmé D
Ann Hematol; 2002; 81 Suppl 2():S66. PubMed ID: 12611080
[No Abstract] [Full Text] [Related]
14. New vessel formation and aberrant VEGF/VEGFR signaling in acute leukemia: does it matter?
de Bont ES; Neefjes VM; Rosati S; Vellenga E; Kamps WA
Leuk Lymphoma; 2002 Oct; 43(10):1901-9. PubMed ID: 12481883
[TBL] [Abstract][Full Text] [Related]
15. Double target for tumor mass destruction.
Saharinen P; Alitalo K
J Clin Invest; 2003 May; 111(9):1277-80. PubMed ID: 12727916
[No Abstract] [Full Text] [Related]
16. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases.
Kim MH
J Cell Biochem; 2003 Jun; 89(3):529-38. PubMed ID: 12761886
[TBL] [Abstract][Full Text] [Related]
17. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.
La Rosa S; Uccella S; Finzi G; Albarello L; Sessa F; Capella C
Hum Pathol; 2003 Jan; 34(1):18-27. PubMed ID: 12605362
[TBL] [Abstract][Full Text] [Related]
18. VEGF signaling is required for the assembly but not the maintenance of embryonic blood vessels.
Argraves WS; Larue AC; Fleming PA; Drake CJ
Dev Dyn; 2002 Nov; 225(3):298-304. PubMed ID: 12412012
[TBL] [Abstract][Full Text] [Related]
19. A targeted approach for antiangiogenic therapy of metastatic human colon cancer.
Ellis LM
Am Surg; 2003 Jan; 69(1):3-10. PubMed ID: 12575772
[TBL] [Abstract][Full Text] [Related]
20. Molecular control of lymphangiogenesis.
Baldwin ME; Stacker SA; Achen MG
Bioessays; 2002 Nov; 24(11):1030-40. PubMed ID: 12386934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
